Colon Cancer, Dysplasia, and Surveillance in Patients with Ulcerative Colitis

New England Journal of Medicine

Volumn 316, Issue 26, 1987, Pages 1654-1658

  Collins, Robert H ^a   Feldman, Mark ^b   Fordtran, John S ^a  

^a BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

^b VA NORTH TEXAS HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER SCREENING; COLON CANCER; DIAGNOSIS; DYSPLASIA; HISTOLOGY; HUMAN; LARGE INTESTINE; PRIORITY JOURNAL; REVIEW; SHORT SURVEY; ULCERATIVE COLITIS;

COLITIS, ULCERATIVE; COLONIC NEOPLASMS; HUMAN; INTESTINAL MUCOSA; PRECANCEROUS CONDITIONS; RISK; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0023237958     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM198706253162609     Document Type: Editorial

References (49)

1. Cello JP. Ulcerative colitis. In: Sleisenger MH, Fordtran JS, eds. Gastrointestinal disease: pathophysiology, diagnosis, management. 3rd ed. Philadelphia: W.B. Saunders. 1983:1122–68.
2. Korelitz BI. Inflammatory bowel disease and cancer. In: Berk JE, Haubrich WS, Kalser MH, Roth JLA, Schaffner F, eds. Bockus gastroenterology. Vol. 4. 4th ed. Philadelphia: W.B. Saunders, 1985:2346–61.
3. Sugarbaker PH, Gunderson LL, Wittes RE. Colorectal cancer. In: DeVita VT Jr, Hellman S. Rosenberg SA, eds. Cancer: principles and practice of oncology. Vol. 1. 2nd ed. Philadelphia: J.B. Lippincott, 1985:795–884.
4. Medical knowledge self-assessment program VII. Part 2. Book B. Philadelphia: American College of Physicians, 1986:20–1.
5. Nefzger MD, Acheson ED. Ulcerative colitis in the United States Army in 1944: follow-up with a particular reference to mortality in cases and controls. Gut 1963; 4: 183–92.
6. Nedbal J, Maratka Z. Ulcerative proctocolitis in Czechoslovakia. Am J Proctol 1968; 19: 106–14.
7. Devroede GJ, Taylor WF, Sauer WG, Jackman RJ, Stickler GB. Cancer risk and life expectancy of children with ulcerative colitis. N Engl J Med 1971; 285: 17–21.
8. Greenstein AJ, Sachar DB, Smith H, et al. Cancer in universal and left-sided ulcerative colitis: factors determining risk. Gastroenterology 1979; 77: 290–4.
9. Prior P, Gyde SN, Macartney JC, Thompson H, Waterhouse JAH, Allan RN. Cancer morbidity in ulcerative colitis. Gut 1982; 23: 490–7.
10. Katzka I, Brody RS, Morris E, Katz S. Assessment of colorectal cancer risk in patients with ulcerative colitis: experience from a private practice. Gastroenterology 1983; 85: 22–9.
11. Kewenter J, Ahlman H, Hulten L. Cancer risk in extensive ulcerative colitis. Ann Surg 1978; 188: 824–8.
12. Hendriksen C, Kreiner S, Binder V. Long term prognosis in ulcerative colitis — based on results from a regional patient group from the county of Copenhagen. Gut 1985; 26: 158–63.
13. Gilat T, Zemishlany Z, Ribak J, Benaroya Y, Lilos P. Ulcerative colitis in the Jewish population of Tel-Aviv Yafo. Gastroenterology 1974; 67: 933–8.
14. Edwards FC, Truelove SC. The course and prognosis of ulcerative colitis. Gut 1964; 5: 1–22.
15. Bargen JA, Gage RP. Carcinoma and ulcerative colitis: prognosis. Gastroenterology 1960; 39: 385–93.
16. Farmer RG, Hawk WA, Turnbull RB. Carcinoma associated with mucosal ulcerative colitis and with transmural colitis and enteritis (Crohn's disease). Cancer 1971; 28: 289–92.
17. MacDougall IPM, Lond MD. The cancer risk in ulcerative colitis. Lancet 1964; 2: 655–8.
18. Sedlock RE, Nobrega FT, Kurland LT, Sauer WG. Inflammatory colon disease in Rochester, Minnesota, 1935–1964. Gastroenterology 1972; 62: 935–41.
19. Sackett DL, Whelan G. Cancer risk in ulcerative colitis: scientific requirements for the study of prognosis. Gastroenterology 1980; 78: 1632–5.
20. Whelan G. Cancer risk in ulcerative colitis: Why are results in the literature so varied? Clin Gastroenterol 1980; 9: 469–76.
21. Gilat T. Incidence of inflammatory bowel disease: Going up or down? Gastroenterology 1983; 85: 196–7.
22. Devroede G. Risk of cancer in inflammatory bowel disease. In: Winawer SJ, Schottenfeld D, Sherlock P, eds. Colorectal cancer: prevention, epidemiology, and screening. New York: Raven Press. 1980:325–34.
23. Butt JH. Lennard-Jones JE, Ritchie JK. A practical approach to the risk of cancer in inflammatory bowel disease: Research, watch, or act? Med Clin North Am 1980; 64: 1203–20.
24. Rosenstock E, Farmer RG, Petras R. Sivak MV Jr, Rankin GB, Sullivan BH. Surveillance for colonic carcinoma in ulcerative colitis. Gastroenterology 1985; 89: 1342–6.
25. Butt JH, Price A, Williams CB. Dysplasia and cancer in ulcerative colitis. In: Allan RN, Norman R, eds. Inflammatory bowel diseases. Edinburgh: Churchill Livingstone, 1983:140–53.
26. Riddell RH, Goldman H, Ransohoff DF, et al. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol 1983; 14: 931–66.
27. Lennard-Jones JE, Morson BC, Ritchie JK, Williams CB. Cancer surveillance in ulcerative colitis: experience over 15 years. Lancet 1983; 2: 149–52.
28. Blackstone MO, Riddell RH, Rogers BHG, Levin B. Dysplasia-associated lesion or mass (DALM) detected by colonoscopy in long-standing ulcerative. colitis: an indication for colectomy. Gastroenterology 1981; 80: 366–74.
29. Granqvist S, Gabrielsson N, Sundelin P, Thorgeirsson T. Precancerous lesions in the mucosa in ulcerative colitis. Scand J Gastroenterol 1980; 15: 289–96.
30. Lennard-Jones JE, Morson BC, Path FRC, Ritchie JK, Shove DC, Williams CB. Cancer in colitis: assessment of the individual risk by clinical and histological criteria. Gastroenterology 1977; 73: 1280–9.
31. Morson BC. Pang LSC. Rectal biopsy as an aid to cancer control in ulcerative colitis. Gut 1967; 8: 423–34.
32. Nugent FW. Haggitt RC, Colcher H, Kutteruf GC. Malignant potential of chronic ulcerative colitis: preliminary report. Gastroenterology 1979; 76: 1–5.
33. Nugent FW. Surveillance of patients with ulcerative colitis: Lahey Clinic results. In: Winawer SJ, Schottenfeld D, Sherlock P, eds. Colorectal cancer: prevention, epidemiology, and screening. New York: Raven Press, 1980:375–80.
34. Nugent FW, Haggitt RC. Results of a long-term prospective surveillance program for dysplasia in ulcerative colitis. Gastroenterology 1984; 86: 1197.
35. Cook MG, Path MRC, Goligher JC. Carcinoma and epithelial dysplasia complicating ulcerative colitis. Gastroenterology 1975; 68: 1127–36.
36. Teague RH, Read AE. Polyposis in ulcerative colitis. Gut 1975; 16: 792–5.
37. Yardley JH. Keren DF. “Precancer” lesions in ulcerative colitis: a retrospective study of rectal biopsy and colectomy specimens. Cancer 1974; 34: 835–44.
38. Myrvold HE, Kock NG, AÅhrén C. Rectal biopsy and precancer in ulcerative colitis. Gut 1974; 15: 301–4.
39. Fenoglio CM. Pascal RR. Adenomatous epithelium, intraepithelial anaplasia, and invasive carcinoma in ulcerative colitis. Am J Dig Dis 1973; 18: 556–62.
40. Hultén L, Kewenter J, Åhrén C. Precancer and carcinoma in chronic ulcerative colitis: a histopathological and clinical investigation. Scand J Gastroenterol 1972; 7: 663–9.
41. Evans DJ. Pollack DJ. In situ and invasive carcinoma of the colon in patients with ulcerative colitis. Gut 1972; 13: 566–70.
42. Ransohoff DF, Riddell RH. Levin B. Ulcerative colitis and colonic cancer: problems in assessing the diagnostic usefulness of mucosal dysplasia. Dis Colon Rectum 1985; 28: 383–8.
43. Eddy D. ACS report on the cancer-related health checkup. CA 1980; 30: 193–240.
44. Lennard-Jones JE. Cancer risk in ulcerative colitis: surveillance or surgery. Br J Surg 1985; 72: Suppl: S84–S86.
45. Krejs GJ. Southwestern Internal Medicine Conference: colon cancer — now a presidential disease. Am J Med Sci (in press).
46. Simon JB. Occult blood screening for colorectal carcinoma: a critical review. Gastroenterology 1985; 88: 820–37.
47. Doll R. General epidemiologic considerations in etiology of colorectal cancer. In: Winawer SJ, Schottenfeld D, Sherlock P, eds. Colorectal cancer: prevention, epidemiology, and screening. New York: Raven Press, 1980: 3–12.
48. Winawer SJ, Andrews M, Miller CH, Fleisher M. Review of screening for colorectal cancer using fecal occult blood testing. In: Winawer SJ, Schottenfeld D, Sherlock P, eds. Colorectal cancer: prevention, epidemiology, and screening. New York: Raven Press, 1980:249–59.
49. Gilbertsen VA. McHugh RB. Schuman LM, Williams SE. Colon Cancer Control Study: an interim report. In: Winawer SJ, Schottenfeld D, Sherlock P, eds. Colorectal cancer: prevention, epidemiology, and screening. New York: Raven Press, 1980:261–6.